Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata
Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata: a Pilot Study of Patient Tolerability
Sponsor: University Hospitals Cleveland Medical Center
Terminated
Lack of participants
Other terminated trials from University Hospitals Cleveland Medical Center
- Diabetes Mellitus, Type 2 · Phase PHASE4 · Jan 2023
- Cervical Spine Surgeries · Phase NA · Feb 2022
- Abdominal Surgery · Phase NA · Mar 2021
- Scar · Phase PHASE4 · Aug 2019
- Safety Issues · Phase NA · May 2019
See all terminations from University Hospitals Cleveland Medical Center
A PHASE4 clinical study on Alopecia Areata, this trial is terminated or withdrawn. The trial is conducted by University Hospitals Cleveland Medical Center and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Feb 2024 — Jul 2024 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
May 2023 — Feb 2024 [monthly]
Recruiting PHASE4
-
May 2022 — May 2023 [monthly]
Recruiting PHASE4
Phase: EARLY_PHASE1 → PHASE4
▶ Show 1 earlier version
-
Apr 2022 — May 2022 [monthly]
Recruiting EARLY_PHASE1
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospitals Cleveland Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .